CUSIP 48576U205COM NEWKPTIQ4 2025
12 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Opaleye Management Inc. | 930.0K | $6.84M |
| 2 | Affinity Asset Advisors, LLC | 889.6K | $6.55M |
| 3 | Vanguard Group Inc | 559.6K | $4.12M |
| 4 | Ikarian Capital, LLC | 544.6K | $4.01M |
| 5 | Soleus Capital Management, L.P. | 440.0K | $3.24M |
| 6 | Adage Capital Partners Gp, L.L.C. | 421.3K | $3.10M |
| 7 | Davidson Kempner Capital Management LP | 310.0K | $2.28M |
| 8 | Braidwell LP | 303.4K | $2.23M |
| 9 |
| 4 | Jan 29, 2026 | Affinity Asset Advisors, LLC | 13G/A | 8.6% | 1.71M | SEC |
| 5 | Nov 14, 2025 | Highbridge Capital Management, LLC | 13G/A | 4.9% | 650.0K | SEC |
| 6 | Nov 7, 2025 | T. Rowe Price Investment Management, Inc. | 13G/A | 13.8% | 2.30M | SEC |
| 7 | Nov 3, 2025 | J. Wood Capital Advisors LLC | 13G/A | 5.0% | 1.00M | SEC |
| 8 | Oct 30, 2025 | The Vanguard Group | 13G/A | 4.7% | 408.2K | SEC |
| 9 | Oct 17, 2025 | Opaleye Management Inc. | 13G | 9.5% | 1.57M | SEC |
| 10 | Aug 14, 2025 | T. Rowe Price Investment Management, Inc. | 13G | 8.4% | 728.8K | SEC |
See the full Schedule 13D/13G history for Karyopharm Therapeutics Inc.
Unlock full history| Exome Asset Management LLC |
| 295.5K |
| $2.18M |
| 10 | Ameriprise Financial Inc | 276.9K | $2.04M |